Food processing and aviation equipment manufacturer JBT Marel (NYSE: JBTM) missed Wall Street’s revenue expectations in Q3 2026, with sales flat year on year at $994 million. The company’s full-year revenue guidance of $3.98 billion at the midpoint came in 1.2% below analysts’ estimates. Its non-GAAP profit of $2.19 per share was 4.5% above analysts’ consensus estimates.
Is now the time to buy JBTM? Find out in our full research report (it’s free for active Edge members).
JBT Marel (JBTM) Q3 2026 highlights:
- Revenue $994 million vs S&P analysts’ estimates of $1.03 billion (flat year on year, 3.3% miss)
- Adjusted EPS $2.19 vs S&P analysts’ estimates of $2.10 (4.5% beat)
- Adjusted EBITDA $179 million vs analyst estimates of $177.3 million (18% margin, 0.9% beat)
- Revenue guidance The company dropped its revenue guidance for the full year to $3.98 billion at the midpoint from $4.03 billion, a 1.3% decrease
- Adjusted EPS guidance Management raised its full-year adjusted EPS guidance to $8.25 at the midpoint, a 1.9% increase
- EBITDA guidance $690.5 million at the midpoint for the full year, in line with analyst expectations
- Operating margin 10.1%, in line with the same quarter last year
- Backlog $1.52 billion at quarter end
- Market capitalization $5.93 billion
StockStory’s take
JBT Marel’s third quarter results received a positive response from the market as management emphasized the company’s ability to maintain profitability and expand margins despite revenue coming in below Wall Street expectations. CEO Brian Deck attributed the steady performance to robust demand in the Protein Solutions segment—particularly poultry—and effective cost controls, including ongoing footprint optimization and productivity improvements. Deck also highlighted solid progress in warehouse automation and the benefits of the post-merger integration, which have contributed to improved operational efficiency.
Looking to the remainder of the year, management’s updated guidance is shaped by a cautious outlook in the Diversified Food and Health (DF&H) subsegment, where demand from consumer packaged goods (CPG) customers remains soft. CFO Matt Meister stated that the company’s improved margin outlook for the year is underpinned by disciplined cost management, supply chain optimization, and targeted footprint consolidation. CEO Brian Deck emphasized the potential for margin expansion through further productivity gains and highlighted opportunities tied to regulatory changes in the poultry industry, noting, “the anticipated USDA ruling regarding higher line speeds could provide an additional multi-year tailwind for U.S. investments.”
Key insights from management’s remarks
Management pointed to a mix of internal execution and external market dynamics as key drivers in the quarter, with particular strength in Protein Solutions and warehouse automation offsetting CPG end market weakness.
-
Protein Solutions momentum: The segment continued to deliver growth, driven by strong poultry volumes and improved margins from cost synergies, pricing, and operational leverage. Management noted a healthy global pipeline, with specific mention of underinvestment in U.S. poultry facilities providing long-term demand.
-
CPG and DF&H softness: Weakness in the consumer packaged goods subsegment of Prepared Food and Beverage Solutions persisted, as customers delayed investments due to inflation and cash preservation. Management indicated that while short-term demand is flat, longer-term project orders have started to pick up as customers prepare for new product launches.
-
Warehouse automation recovery: The warehouse automation division, after restructuring, showed meaningful cost improvements and resumed revenue growth, contributing positively to segment margins. Management credited better backlog and project execution for the turnaround.
-
Footprint optimization advances: JBT Marel completed five facility closures in the quarter as part of its ongoing operational consolidation. These changes are expected to yield further cost savings and productivity improvements, with larger facility shutdowns planned for next year to deepen the impact.
-
Integration and synergy realization: The company continues to realize both cost and revenue synergies from the JBT-Marel merger, exceeding initial targets, especially by cross-selling prepared foods and secondary poultry solutions. Management sees additional opportunity for synergy capture through unified software, digital services, and customer support.
Drivers of future performance
Management expects future performance to hinge on resolving CPG end market weakness, continued cost discipline, and capitalizing on industry-specific growth opportunities.
-
Poultry investment cycle: Management highlighted that anticipated regulatory changes, specifically a USDA decision on poultry line speeds, could drive multi-year capital investment in U.S. poultry processing. JBT Marel’s leadership position in both primary and secondary poultry solutions puts it in a favorable position to benefit if these regulatory shifts materialize.
-
Operational improvements and synergies: Further gains are anticipated from ongoing footprint rationalization, supply chain optimization, and automation initiatives. Management pointed out that these efforts are essential to delivering the company’s EBITDA margin target of 20% by 2028 and offsetting inflation and tariffs.
-
CPG and DF&H recovery timing: The near-term outlook for the Diversified Food and Health subsegment remains uncertain, as customers continue to limit spending amid macroeconomic pressures. Management is monitoring signs of a pickup in long-term project orders, but expects short-term headwinds to persist for at least another quarter or two.
Catalysts in upcoming quarters
Looking ahead, the StockStory team will be tracking (1) progress toward further margin expansion through facility consolidations and supply chain optimization, (2) signs of recovery or stabilization in CPG and DF&H demand, and (3) the outcome and potential impact of the USDA ruling on poultry processing line speeds. Additional attention will be paid to the pace of synergy capture and customer adoption of integrated digital and service offerings.
JBT Marel currently trades at $116.76, up from $114.89 just before the earnings. Is there an opportunity in the stock? See for yourself in our full research report (it’s free).
Our favorite stocks right now
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
